Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Broadcom

Kinder Morgan

NIKE

Could dividend stocks be the way to go as investors consider the possible economic effects of the Omicron variant?

Best Dividend Stocks In 2021? 4 To Watch In December 2021

AutoZone

Best Buy

CVS Health

Home Depot

Kroger

Rite Aid

Target

The chief executives of major U.S. retailers including Target, Home Depot, Kroger, CVS Health, Autozone and Best Buy on Thursday urged Congress to take action to address some anonymous online sales, citing the growing impact of organized retail crime.

Major U.S. retailers urge action by Congress on online sellers

DEERFIELD, Ill.--(BUSINESS WIRE)--WBA will release its fiscal 2022 first quarter earnings results at 7 a.m. Eastern time Thursday, Jan. 6, 2022.

Walgreens Boots Alliance Schedules Fiscal 2022 First Quarter Earnings Announcement for January 6, 2022

Walgreens Boots Alliance (WBA) closed at $48.23 in the latest trading session, marking a -0.14% move from the prior day.

Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know

DEERFIELD, Ill.--(BUSINESS WIRE)--This December, Walgreens and Mental Health America (MHA) are teaming up to provide support for mental health this holiday season. Together, Walgreens and MHA are asking people to donate to a virtual ‘Swear Jar' when they experience the inevitable holiday hiccups that make them want to yell out a ‘humbug.' MHA is the leading community based nonprofit organization dedicated to addressing the needs of those living with mental illness and to promoting the overall m

Walgreens and Mental Health America Team Up to Raise Funds and Provide Mental Health Support This Holiday Season

Walgreens Boots Alliance has engaged Goldman Sachs as advisors to explore options of the UK Boots chain.

Walgreens Lines Up Goldman Sachs To Explore Options For Boots Chain

Walgreens Boots Alliance Inc. is working with Goldman Sachs on a possible sale of 172-year-old U.K. health and beauty retailer Boots, according to a Sky News report. The process remains in the “exploratory” stage, the report says, meaning a sale is far from a sure thing.

Walgreens Considering Sale of Boots Alliance

Walgreens Boots Alliance Inc (NASDAQ: WBA) has reportedly lined up Goldman Sachs to advise it on reviewing options for Britain's high street chemist, Boots. Spinning the chain off into a separately listed company could also be a possibility, reported Sky News.

Walgreens To Explore Options For UK's Boots Pharmacy Chain: Sky News

Amgen

American Express

Boeing

Salesforce

Chevron

Disney

Dow Inc

Intel

Coca-Cola

Merck

Visa

Verizon

"The Dow [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration."– Dow Jones & Co. Thirty-one Dow stocks represent nine of eleven sectors. Dow tracks utilities as a separate index and omits real estate. Broker top-ten target-estimated net gains ranged 24.29%-43.88% topped by V 12/1/21.

Dogs Of The Dow Hit December Sporting 2 To Buy

Walgreens Boots Alliance is reviewing options to sell or spin off assets including its Boots pharmacies in the United Kingdom, media reports in the U.K. say.

Report: Walgreens May Sell Or Spin Off European Boots Drugstores

Of late, increased reimbursement pressure and generic drug cost inflation have been hampering Walgreens Boots' (WBA) margin significantly.

Walgreens Boots (WBA) Faces Margin Pressure, Solvency Issue

Walgreens CEO Roz Brewer said the company's multi-billion dollar push into primary care and post-acute services is designed to “keep people from returning to the system of healthcare.”

Walgreens CEO Brewer: Primary Care Goal To Keep People Away From ‘The System Of Healthcare'

Advanced Micro Devices

Amazon

Robinhood

Tesla

Walmart

U.S. retirement savings today are heavily dependent on the stock market. Technology has transformed investor's understanding and access to the system and has unleashed the era of impatience.

This Isn't Your Father's Market: Long Live Income

Walgreens' (WBA) recent acquisition of the remaining ownership stake helps the company to further solidify its position as a leading pharmaceutical wholesaler in Germany.

Walgreens (WBA) Buys Remaining Stake in German Wholesale Business

AbbVie

Abbott Labs

Johnson & Johnson

Medtronic

Just when you thought it was starting to look safer, yet another COVID-19 variant comes around.

5 Health Care Dividend Aristocrats to Buy for 2022 as Yields Plunge Once Again

SANTA ANA, Calif.--(BUSINESS WIRE)--Western Dental, the Southern California Chapter of NFL Alumni and Walgreens will hold a free COVID vaccination clinic 11 a.m. Dec. 4 in Santa Ana.

Western Dental and NFL Alumni Host Holiday Block Party with Walgreens to Provide Free COVID Vaccinations

McKesson

DEERFIELD, Ill. & IRVING, Texas--(BUSINESS WIRE)--WBA, McKesson announce WBA to acquire the remaining 30% share of their GEHE Pharma Handel (GEHE) & Alliance Healthcare Deutschland (AHD) joint venture

Walgreens Boots Alliance Acquires Remaining Stake in German GEHE-Alliance Healthcare Joint Venture From McKesson

Evercore

Walgreens Boots Alliance, Inc (WBA) CEO Rosalind Brewer at 4th Annual Evercore ISI HealthCONx Virtual Conference (Transcript)

Aflac

Amcor Plc

Atmos Energy

Becton, Dickinson and Co.

Cardinal Health

Caterpillar

Chubb

Clorox

Ecolab

General Dynamics

Hormel Foods

New Linde PLC

Lowe's

McDonald's

Nucor

Sysco

AT&T

V.F.

Even after the dip on Black Friday NOBL is still having a positive return in November. I present 3 strategies that theoretically can beat the dividend aristocrat index in the long term.

Best Dividend Aristocrats For December 2021

Novavax

Ping Identity Holding Corp

It's easy to make money when you buy high-quality stocks and allow time to be your ally.

4 No-Brainer Stocks to Invest $300 In Right Now

Walgreens estimates savings of $3.3B from its Transformational Cost Management program by 2024.

Walgreens Pushes Further Into Personalized Healthcare

Jurors in Cleveland federal court have determined that pharmacy chain operators CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance Inc (NASDAQ: WBA), and Walmart Inc (NYSE: WMT) helped fuel the opioid epidemic in two counties in Ohio, Reuters reports. The jurors concluded that the companies helped create a public nuisance through an abundant supply of pain killers and diversion of those drugs to the black market.

US Jury Finds Pharmacy Chains Did Not Monitor Opioid Usage, Thus Fueling Epidemic: Reuters

News for Walgreens Stock (WBA)